Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2005-05-23
2010-06-08
Saoud, Christine J (Department: 1649)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S141100, C424S130100, C435S070210, C530S388100
Reexamination Certificate
active
07731965
ABSTRACT:
The present invention relates to antibodies that specifically bind to human BNP and immunoassays using said antibodies in the quantification of human BNP or a fragment of human BNP in a test sample.
REFERENCES:
patent: 4399216 (1983-08-01), Axel et al.
patent: 4510245 (1985-04-01), Cousens et al.
patent: 4607023 (1986-08-01), Thibault et al.
patent: 4634665 (1987-01-01), Axel et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4968615 (1990-11-01), Koszinowski et al.
patent: 5114923 (1992-05-01), Seilhamer et al.
patent: 5168062 (1992-12-01), Stinski
patent: 5179017 (1993-01-01), Axel et al.
patent: 5468646 (1995-11-01), Mattingly et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5674710 (1997-10-01), Seilhamer et al.
patent: 6090382 (2000-07-01), Salfeld et al.
patent: 6117644 (2000-09-01), DeBold
patent: 6124430 (2000-09-01), Mischak et al.
patent: 6162902 (2000-12-01), Mischak et al.
patent: 6376207 (2002-04-01), Mischak et al.
patent: 6461828 (2002-10-01), Stanton et al.
patent: 6677124 (2004-01-01), Tsuji et al.
patent: 7341838 (2008-03-01), Buechler et al.
patent: 7351586 (2008-04-01), Friese et al.
patent: 2003/0022235 (2003-01-01), Dahlen et al.
patent: 2003/0162710 (2003-08-01), Sudoh et al.
patent: 2003/0199000 (2003-10-01), Valkirs et al.
patent: 2004/0132013 (2004-07-01), DeBold
patent: 2004/0175379 (2004-09-01), DeVries et al.
patent: 2004/0180396 (2004-09-01), Bergmann et al.
patent: 2004/0209307 (2004-10-01), Valkirs et al.
patent: 2004/0219509 (2004-11-01), Valkirs et al.
patent: 2004/0243010 (2004-12-01), Zoghbi et al.
patent: 2004/0253655 (2004-12-01), Tsuji et al.
patent: 2005/0014287 (2005-01-01), Friese et al.
patent: 2005/0064511 (2005-03-01), Buechler et al.
patent: 2006/0121042 (2006-06-01), Dall' Acqua et al.
patent: 2006/0183154 (2006-08-01), Shih et al.
patent: 0418308 (1995-08-01), None
patent: 384176 (1995-12-01), None
patent: 5 422 55 (1999-02-01), None
patent: 914344 (2005-06-01), None
patent: 1030177 (2005-06-01), None
patent: 1 016 867 (2006-01-01), None
patent: 3-297392 (1991-12-01), None
patent: 2676114 (1997-11-01), None
patent: 2004/094460 (2004-11-01), None
Benjamini et al. Immunology, a short course. 2nd edition, Wiley-Liss. 1991, p. 40.
von Mehren et al. Curr. Opin. Oncol. 1996. 8: 493-8.
Bogan, et al., J. Mol. Biol. 280, 1-9,(1998).
Cataliotti, et al., Mayo Clin. Proc. 76, 1111-1119, (2001).
Davidson, et al., Journal of Hypertension 12(4), 329-336, (1994).
Galfre, et al., Nature 266, 550-552 (1977).
Ma, et al., PNAS 100(10), 5772-5777, (2003).
Morrison, et al., Proc. Natl. Acad. Sci. USA, 81, 6851-6855 (1984).
Motwani, Lancet 341, 1109-1113 (1993).
Mukoyama, et al., J. Clin. Invest. 87, 1402-1412 (1991).
Shimizu, et al, Clinica chimica Acta 316, 129-135 (2002).
Thorpe, et al., Scandinavian Journal of Immunology 57, 85-92 (2003).
Valli, et al., J. Lab. Clin. Med. 134(5), 437-444 (1999).
Yandle, et al., Journal of Internal Medicine 235, 561-576, (1994).
Yoshibayashi, et al. New Eng. J. Med. 327, 434-434 (1993).
Apple, F.S., et al., “Quality Specifications for B-Type Natruiuretic Peptide Assays”, Clin. Chem., 51(3):486-493 (2005).
Axsym BNP package insert, Abbott Diagnostic Division, Feb. 2004.
Belenky, A., et al., “The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma”, Clinica Chimica Acta, 340:163-172 (2004).
Berzofsky, J.A., et al., “Antigen-Antibody interactions and Monoclonal Antibodies”, Fund. Immunol., 2:315-336 (1998).
Bird, R.E., et al., “Single-Chain Antigen-Binding Proteins”, Science, 242:423-426 (1988).
Bluestein, B., “Comparing BNP Assays”, Bayer Healthcare Diagnostic Div. Publ., (2004).
Boder, E.T. 7 Wittrup, K.D., “Optimal Screening of Surface-Displayed Polypeptide Libraries”, Biotechnol. Prog., 14:55-62 (1998).
Boder, E.T. & Wittrup, K.D., “Yeast Surface Display for Directed Evolution of Protein Expression, Affinity, and Stability”, Meth. in Enzymol., 10:430-444 (1999).
Boder, E.T. & Wittrup, K.D., “Yeast surface display for screening combinatorial polypeptide libraries”, Nature Biotech., 15:553-557 (1997).
Boder, E.T., et al., “Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity”, PNAS, 97(20):10701-10705 (2000).
Boss, M.A. & Wood, C.R., “Genetically engineered antibodies”, Immunol. Today 6(1):12-13 (1985).
Brandt, I., et al., “Dipeptidyl-Peptidase IV Converts Intact B-Type Natriuretic Peptide into Its des-SerPro Form”, Clinical Chem., 52(1):82-87 (2006).
Brown, T., “Hybridization Analysis of DNA Blots”, Curr. Protocols in Molec. Biol., 2.10.1-2.10.3 (1997).
Buckley, M.G., “Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice”, Clin. Sci., 97:689-695 (1999).
Diagnostic Automation/Cortez Diagnostics, Inc., “Nt-proBNP ELISA Quantitative Determination of Nt-proBNP in Biological Fluids”, (Cat. No. 2852-7), pp. 1-8 (1997).
Gutkowska, J., et al., “Atrial Natriuretic Factor in Human Plasma”, Biochem. & Biophys. Res. Comm., 139 (1):287-295 (1986).
Holmes, S.J., et al., “Renal, Endocrine, and Hemodynamic Effects of Human Brain Natriuretic Peptide in Normal Man”, J. of Clin. Endocrinol. & Metab., 76(1):91-96 (1993).
Huston, J.S., et al., “Protein engineering of antibody binding sites: Recovery of specific activity in a anti-digoxin single-chain Fv analogue produced inEscherichia coli”, PNAS, 85:5879-05883 (1988).
Itoh, H., et al., “Preparation of Monoclonal Antibodies against Brain Natriuretic Peptide and Their Application to Radioimmunoassay and Passive Immunization”, Endocrinology, 127(3):1292-1330 (1990).
Kabat, et al., U S Dept. of Health & Human Serv., NIH Publ 91-3242, 5th Ed., Tbl. of Cont.
Kaufman, R.J. & Sharp, P.A., “Amplification and Expression of Sequences Cotransfected with a Modular Dihydrofolate Reductase Complementary DNA Gene”, J. Mol. Biol., 159:601-621 (1982).
Kenny, A.J., et al., “Hydrolysis of human and pig brain natiruretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11”, Biochem. J., 291:83-88 (1993).
Mizushima, S. & Nagata, S., “pEF-BOS, a powerful mammalian expression vector”, Nucl. Acids Res., 18(17):5322 (1990).
Murdoch, D.R., et al., “Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice”, Heart, 78:594-597 (1997).
Nordin, H., et al., “Kinetic studies of small molecule interactions with protein kinases using biosensor technology”, Analyt. Biochem., 340:359-368 (2005).
Rajpal, A., et al., “A general method for greatly improving the affinity of antibodies by using combinatorial libraries”, PNAS, 102(24):8466-8471 (2005).
Sanz, M.P., et al., “Comparison of BNP and NT-proBNP Assays in the Approach to the Emergency Diagnosis of Acute Dyspnea”, J. of Clin. Lab. Analy., 20:227-232 (2006).
Schiestl, R.H. & Gietz, R.D., “High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier”, Curr. Genet., 16:339-346 (1989).
Shimizu, H., et al., “Degradation of human brain natriuretic peptide (BNP) by contact activation of blood coagulation system”, Clinica Chimica Acta, 305:181-186 (2001).
Strauss, W.M., “Hybridization with Radioactive Probes”, Curr. Protocols in Molec. Biol., 6.3.1-6.3.6 (1997).
Tetin, S.Y., et al., “Interactions of Two Monoclonal Antibodies with BNP: High Resolution Epitope Mapping Using Fluorescence Correlation Spectroscopy”, Biochem., 45:14155-14165 (2006).
Urlaub, G. & Chasin, L.A., “Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity”, PNAS, 77(
Brophy Susan E.
Dagfal David J.
Hawksworth David J.
Matias Matthew S.
Pinkus Mary S.
Bartnicki Audrey L.
Saoud Christine J
Wang Chang-Yu
LandOfFree
Human ring specific BNP antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human ring specific BNP antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human ring specific BNP antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4161644